Allergens, Inhalants, Northeast Comprehensive
Also known as: NORTHEAST
Use
The Allergens, Inhalants, Northeast Comprehensive test is used to quantitatively measure specific IgE antibodies to a comprehensive panel of inhalant allergens common in the Northeast region. This test aids in the diagnosis of allergic conditions and assists in the management of allergy symptoms by identifying specific allergen sensitivities. IgE levels in response to individual allergens are measured and reported to help guide clinical decisions regarding patient management, such as avoidance strategies, pharmacotherapy, or allergen-specific immunotherapy.
Special Instructions
Not provided.
Limitations
This test measures allergen-specific IgE levels, which may not directly correlate with clinical response or skin testing results when the patient is exposed to allergens. Low levels of specific IgE antibodies might not rule out the possibility of clinical allergy, and some individuals with higher IgE concentrations may not display clinical symptoms. It is essential to combine test results with the patient’s clinical history and in vivo reactivity to specific allergens to determine clinical significance. Cross-reactivity among allergens may also impact results.
FDA ApprovedNew York Approved
Methodology
Immunoassay (Fluorescent Enzyme Immunoassay)
Biomarkers
Result Turnaround Time
1-3 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
1.65 mL
Minimum Volume
0.8 mL
Container
ARUP Standard Transport Tube
Collection Instructions
Separate serum from cells within 2 hours of collection.
Patient Preparation
Multiple patient encounters should be avoided.
Storage Instructions
Refrigerate specimen immediately after separation from cells.
Causes for Rejection
Hemolyzed, icteric, or lipemic specimens.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 48 hours |
| Refrigerated | 2 weeks |
| Frozen | 1 year |
Other tests from different labs that may be relevant